111.48 - 114.40
76.75 - 114.40
5.09M / 4.23M (Avg.)
23.96 | 4.77
Analyze DCF forecasts for the company and compare them with competitors.
54.94B
Better than USLM's revenue of 747.21M.
6.63%
Worse than USLM's revenue growth rate of 18.65%.
9.11B
Better than USLM's ebitda of 280.31M.
16.58%
Worse than USLM's ebitda margin of 37.51%.
6.28B
Better than USLM's ebit of 207.35M.
11.44%
Worse than USLM's ebit margin of 27.75%.
2.82B
Worse than USLM's depreciation of 72.97M.
10.31B
Better than USLM's total cash of 475.92M.
18.77%
Worse than USLM's cash as percentage of revenue of 63.69%.
4.35B
Worse than USLM's receivables of 104.62M.
7.92%
Better than USLM's receivables as percentage of revenue of 14.00%.
6.75B
Worse than USLM's inventories of 64.41M.
12.28%
Worse than USLM's inventories as percentage of revenue of 8.62%.
4.79B
Worse than USLM's accounts payable of 21.53M.
8.73%
Worse than USLM's payables as percentage of revenue of 2.88%.
-2.83B
Better than USLM's capital expenditure of -87.61M.
-5.15%
Worse than USLM's capex as percentage of revenue of -11.73%.
8.64%
Equal to USLM's weighted average cost of capital (wacc) of 8.64%.
10.12%
Worse than USLM's cost of equity of 8.65%.
4.08%
Worse than USLM's cost of debt of 4.07%.
1.28
Worse than USLM's beta of 0.97.
689.50M
Worse than USLM's diluted shares outstanding of 28.69M.
17.15B
Worse than USLM's total debt of 5.04M.
64.88B
Better than USLM's total equity of 3.01B.
82.03B
Better than USLM's total capital of 3.02B.
20.91%
Worse than USLM's debt weighting of 0.17%.
79.09%
Worse than USLM's equity weighting of 99.83%.
4.73B
Better than USLM's ebiat of 166.89M.
4.34B
Better than USLM's unlevered free cash flow of 129.06M.
2.00%
Better than USLM's long-term growth rate of 0.50%.
66.61B
Better than USLM's terminal value of 1.59B.
61.24B
Better than USLM's enterprise value of 1.41B.
12.98B
Worse than USLM's net debt of -272.99M.
48.26B
Better than USLM's equity value of 1.69B.
69.99
Better than USLM's equity value per share of 58.78.
Analyze analyst forecasts for the company and compare them with competitors.
33.53B
Better than USLM's estimated revenue of 211.89M.
5.52B
Better than USLM's estimated ebitda of 37.51M.
1.99
Worse than USLM's estimated eps of 2.71.
1.45B
Better than USLM's estimated net income of 24.09M.
3.66B
Better than USLM's estimated ebit of 37.55M.
7.51B
Worse than USLM's estimated sg&a expense of 10.46M.
View analysts' price targets and recommendations, and compare them with competitors.
$114.00
Analysts expect the stock price to decrease by 0.24%.
Buy
Positive consensus among analysts.
